Filing Details

Accession Number:
0001415889-24-001732
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-24 10:49:03
Reporting Period:
2024-01-22
Accepted Time:
2024-01-24 10:49:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
856982 Merit Medical Systems Inc MMSI Surgical & Medical Instruments & Apparatus (3841) 870447695
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1649014 Ann F. Millner 1600 West Merit Parkway
South Jordan UT 84095
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2024-01-22 20,000 $34.40 49,960 No 4 M Direct
Common Stock, No Par Value Disposition 2024-01-22 20,000 $80.00 29,960 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock options (right to buy) Disposition 2024-01-22 20,000 $0.00 20,000 $34.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-24 2024-05-24 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock options (right to buy) $50.50 2019-06-07 2025-06-07 25,000 25,000 Direct
Common Stock Non-qualified stock options (right to buy) $52.17 2020-05-24 2026-05-24 13,750 13,750 Direct
Common Stock Non-qualified stock options (right to buy) $52.17 2020-05-31 2026-05-31 7,500 7,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-06-07 25,000 25,000 Direct
2026-05-24 13,750 13,750 Direct
2026-05-31 7,500 7,500 Direct
Footnotes
  1. The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.
  2. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.000 to $80.035, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
  4. Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
  5. Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
  6. Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.